Big Pharma meets polite paralysis: a tale of risk-averse “innovation,” PowerPoint loyalty tests, and slow-motion ambition. 1. Innovation Is Our Passion — As Long As It’s Pre-approved, Painfully Safe, and Doesn’t Offend Anyone in Tokyo We love innovation. We say it. We write it. We bold it on slide 3 of every deck. But proposing…